Pitch for Investment

Latest Insights, Interviews, News, and Resources.

The latest news from UKI2S and our portfolio companies

Revolver’s Fight Against Childhood Cancer

Funding Boost for Revolver’s Fight Against Childhood Cancer

28th November 2024

Revolver Therapeutics is pleased to announce this new funding is from UK Innovation Science and Seed Fund (UKI2S), managed by Future Planet Capital, and from o2h Ventures to progress its transcription factor inhibitors. These novel peptide inhibitors were discovered using Revolver’s proprietary Transcription Block Survival (TBS) assay platform technology, which was spun out of the University of Bath.
iFAST Diagnostics

iFAST Diagnostics announces $6.5M (£5m) to combat antimicrobial resistance globally

28th November 2024

iFAST has developed a cutting-edge technology that tests bacteria to determine the most effective antibiotics in under three hours. This is a significant advancement compared to the current 48-72 hours required. Using a microchip to analyse thousands of bacteria electrically, the system ensures that patients get the right treatment faster.
Early Detection for All: Sona's New ground-breaking Ultrasound Tech

Early Detection for All: Sona’s New ground-breaking Ultrasound Tech to Make Breast Cancer Screening More Efficient and Save Lives

20th November 2024

Sona, from the world-leading National Physical Laboratory (NPL), will revolutionise breast cancer screening with world’s first innovative ultrasound-based breast density assessment and monitoring technology, that does not require imaging or trained radiologists.
Ikarovec

Ikarovec’s seed round extension brings total to £8M with proceeds to advance lead sight loss programme towards clinic

5th November 2024

Ikarovec, which is developing novel bicistronic gene therapies for major chronic eye diseases, is pleased to announce that it has extended its seed funding round by £5M, bringing the total raised to £8M.
NK:IO

NK:IO Appoints Richard Hopkins as CEO, Finalises £5.9m Seed Funding to Progress Ovarian Cancer Therapy

23rd October 2024

NK:IO completes Seed round to a total of £5.9m, with additional funding from UK Innovation Science and Seed Fund (UKI2S), managed by Future Planet Capital, Cambridge Angels and Cancer Research Horizons.
Aquark Technologies

A boost for quantum sensing: Aquark Technologies raises €5m in seed financing led by NATO Innovation Fund

19th September 2024

Seed round with investments from NATO Innovation Fund, EIFO, UKI2S (managed by Future Planet Capital), and MBDA to boost scale and availability of Aquark’s innovative quantum sensing technology.
UKI2S: one of the UK’s most active early stage investors.

Doing the most to back UK tech. UKI2S: one of the UK’s most active early stage investors

12th September 2024

Early stage investments into the UK’s brightest tech startups are dwindling year on year, according to Dealroom which revealed the lowest deal count since 2016.
HonuWorx

Investors dive in with seven-figure boost for Scots underwater robotics pioneer

12th September 2024

A Scottish underwater robotics firm has received a seven-figure investment into its plans to revolutionise operations in the energy and security sectors.

SOLASTA Bio

SOLASTA Bio Completes $14M Series A to Accelerate Nature-Inspired Crop Protection

11th September 2024

SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A funding round…
Adamo Foods

Adamo Foods Nets $2.5M to Bring Groundbreaking Clean-Label Mycelium Steak to Market

14th August 2024

Proprietary Fermentation Process Mimics the Muscle Structure of Whole-Cut Meat, Promoting Health with Zero Cholesterol and Reducing Emissions by 93%.
HutanBio

UKI2S Backs HutanBio, Further Recognising Biology’s Role in Tackling Climate Change

26th June 2024

UKI2S joins Clean Growth Fund, advancing seed round total to £3 million. UKI2S is investing from its engineering biology portfolio and HutanBio joins its portfolio of high-impact companies.
Wave Photonics

Wave Photonics secures £4.5M ($5.8M) to enable the widespread deployment of light-based chips.

20th June 2024

Wave Photonics, a Cambridge-based deep tech start-up, has received £4.5M to develop on-chip photonics designs for quantum technologies, sensors, and datacentre applications.
UK-based technology startup Mirico

Laser Targeting: Methane-chasing startup Mirico raises $2.0M

13th June 2024

UK-based technology startup Mirico has raised a successful funding round to support its distinctive laser-based sensing and data analytics platform, which is initially focused on finding and eliminating methane leaks from oil & gas infrastructure.
Space - UKI2S

UK Space Agency announces £8m for Space startups with UKI2S, managed by Future Planet Capital

2nd May 2024

Managed by Future Planet Capital. As part of the UK government’s ambitious 10-year vision for the Space Industry, where over £10 billion has been pledged to position the UK as a global leader, the UK Space Agency is…
Patient having temperature taken.

MoD spin-out Presymptom Health raises £1.5m to develop AI-driven sepsis and infection tests for the NHS

22nd March 2024

UK start-up Presymptom Health has raised £1.5m in follow-on seed and grant funding that will help accelerate time to market of its AI-driven sepsis and infection tests.
ExactTrak

UKI2S Portfolio Company ExactTrak secures £1 million investment to fix a gap in cybersecurity

26th February 2024

ExactTrak, a leading player in UK cybersecurity who recently secured a UK Government contract, has successfully raised £1 million to fix a gap in cybersecurity…
HONUWORX

HonuWorx goes subsea, offering game-changing, emission-reducing, economy-boosting tech.

21st February 2024

HonuWorx uses ingenious tech to deliver zero-emission underwater operations and underpin the sustainable growth of clean energy sectors such as offshore wind sector.

image of presympton health

UKI2S portfolio company, Presymptom Health, joins government pilot

15th February 2024

To get AI-driven infection test into the NHS faster helping to tackle Anti-Microbial Resistance.
Productive Machines Technologies

Improve efficiency, productivity and sustainability with Productive Machines

30th January 2024

NetZero by 2030. Responsible investment. Environmental action. Social inclusion. Impact-first – that’s the mission. The driving force behind UKI2S.
Douglas Hansen-Luke

Dinner is Served: Investment Predictions for 2024

11th January 2024

By Douglas Hansen-Luke, Executive Chairman and Founder of Future Planet Capital (FPC) – Fund Manager of UKI2S
Oxford Space Systems

Oxford Space Systems’ £3M Funding Round, Supported by UK Ministry Of Defence contributed through UKI2S

9th January 2024

Supported by UK Ministry Of Defence contributed through UKI2S. Oxford Space Systems announces the successful completion of a £3 million equity investment…
HALO X-ray Technologies

HALO’s novel X-ray diffraction technology will strengthen global security

19th December 2023

Proving its X-ray diffraction technology (XRD) has the potential to enhance security, improve passenger facilitation, increase throughput, and reduce airport operational costs.

An image of the Grand Prismatic Spring (licensed from photographer Werner van Steen), representing the origin of our sulfur-utilizing mitochondrial ancestors

MitoRx Therapeutics Announces Close of Seed Extension Financing Round

13th December 2023

To Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases.
Bioengineering

Ingredients that don’t cost the earth

11th December 2023

Building sustainability with engineering biology and AI…
UKI2S

© UKI2S and Future Planet Capital (Ventures) Limited. All Rights Reserved. UKI2S is managed by Future Planet Capital (Ventures) Limited which is Authorised and Regulated in the UK by the Financial Conduct Authority FRN 148549. Registered in England and Wales. Company Number 2500898. Registered Address: Future Planet Capital (Ventures) Limited, 1 Scott Place, 2 Hardman Street, Manchester, M3 3AA.

Stay updated

UKI2S
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.